SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-4/A - Registration of securities, foreign private issuers, business combinations: [Amend]
SEC Accession No. 0001104659-23-006384
Filing Date
2023-01-25
Accepted
2023-01-25 08:21:16
Documents
68

Document Format Files

Seq Description Document Type Size
1 F-4/A tm2226545-21_f4a.htm F-4/A 11117928
2 EXHIBIT 23.1 tm2226545d23_ex23-1.htm EX-23.1 2503
3 EXHIBIT 23.2 tm2226545d23_ex23-2.htm EX-23.2 3110
4 GRAPHIC lg_summithealthcare-4c.jpg GRAPHIC 50738
5 GRAPHIC lg_ysbiopharma-4c.jpg GRAPHIC 32536
6 GRAPHIC tm2226545d7-fc_corporatebw.jpg GRAPHIC 145554
7 GRAPHIC tm2226545d7-fc_combniatbw.jpg GRAPHIC 100606
8 GRAPHIC tm2226545d1-fc_organibw.jpg GRAPHIC 221881
9 GRAPHIC tm2226545d1-bc_global4clr.jpg GRAPHIC 210882
10 GRAPHIC tm2226545d1-bc_china4clr.jpg GRAPHIC 270650
11 GRAPHIC tm2226545d1-bc_gvaccine4clr.jpg GRAPHIC 282206
12 GRAPHIC tm2226545d1-fc_purchas4c.jpg GRAPHIC 125368
13 GRAPHIC tm2226545d1-lc_median4clr.jpg GRAPHIC 76366
14 GRAPHIC tm2226545d1-bc_rabiesmark4c.jpg GRAPHIC 111327
15 GRAPHIC tm2226545d1-tbl_rabies4clr.jpg GRAPHIC 46905
16 GRAPHIC tm2226545d1-bc_rabiescarr4c.jpg GRAPHIC 57838
17 GRAPHIC tm2226545d1-tbl_cell4c.jpg GRAPHIC 256370
18 GRAPHIC tm2226545d1-tbl_vacsing4c.jpg GRAPHIC 172166
19 GRAPHIC tm2226545d1-tbl_vacphi4c.jpg GRAPHIC 116709
20 GRAPHIC tm2226545d1-tbl_vaccine4c.jpg GRAPHIC 357970
21 GRAPHIC tm2226545d1-tbl_drug4c.jpg GRAPHIC 203574
22 GRAPHIC tm2226545d1-tbl_company4c.jpg GRAPHIC 244663
23 GRAPHIC tm2226545d1-tbl_cde4c.jpg GRAPHIC 200680
24 GRAPHIC tm2226545d1-tbl_hbv4c.jpg GRAPHIC 159681
25 GRAPHIC tb_pipeline-4c.jpg GRAPHIC 393489
26 GRAPHIC tm2226545d7-ph_figure14clr.jpg GRAPHIC 168016
27 GRAPHIC tm2226545d7-lc_figure24c.jpg GRAPHIC 100965
28 GRAPHIC tm2226545d1-fc_phase14clr.jpg GRAPHIC 97189
29 GRAPHIC tm2226545d7-bc_3figure4c.jpg GRAPHIC 90562
30 GRAPHIC tm2226545d1-fc_groupa4clr.jpg GRAPHIC 79663
31 GRAPHIC tm2226545d7-bc_4figure4c.jpg GRAPHIC 81058
32 GRAPHIC tm2226545d1-fc_trials4clr.jpg GRAPHIC 173826
33 GRAPHIC tm2226545d1-tbl_study4clr.jpg GRAPHIC 196665
34 GRAPHIC tm2226545d7-bc_5figure4clr.jpg GRAPHIC 188973
35 GRAPHIC tm2226545d7-bc_figure144clr.jpg GRAPHIC 72923
36 GRAPHIC tm2226545d7-lc_7figure4c.jpg GRAPHIC 118281
37 GRAPHIC tm2226545d7-bc_8figure4c.jpg GRAPHIC 84707
38 GRAPHIC tm2226545d7-bc_9figure4c.jpg GRAPHIC 107937
39 GRAPHIC tm2226545d7-lc_10figure4clr.jpg GRAPHIC 132709
40 GRAPHIC tm2226545d7-bc_11figure4clr.jpg GRAPHIC 149851
41 GRAPHIC tm2226545d7-bc_12figure4c.jpg GRAPHIC 123717
42 GRAPHIC tm2226545d7-bc_13figure4c.jpg GRAPHIC 110704
43 GRAPHIC tm2226545d7-bc_14figure4c.jpg GRAPHIC 92629
44 GRAPHIC tm2226545d1-fc_uae4clr.jpg GRAPHIC 240445
45 GRAPHIC tm2226545d1-bc_figure24c.jpg GRAPHIC 236041
46 GRAPHIC tm2226545d7-bc_armb4c.jpg GRAPHIC 189919
47 GRAPHIC tm2226545d1-fc_trialde4c.jpg GRAPHIC 203545
48 GRAPHIC tm2226545d7-bc_17figure4clr.jpg GRAPHIC 60207
49 GRAPHIC tm2226545d7-bc_18figure4clr.jpg GRAPHIC 63344
50 GRAPHIC tm2226545d7-bc_19figure4clr.jpg GRAPHIC 79784
51 GRAPHIC tm2226545d7-ph_figure64clr.jpg GRAPHIC 297363
52 GRAPHIC tm2226545d7-bc_21figure4clr.jpg GRAPHIC 129355
53 GRAPHIC tm2226545d7-bc_figure84clr.jpg GRAPHIC 245676
54 GRAPHIC tm2226545d7-bc_23figure4c.jpg GRAPHIC 152956
55 GRAPHIC tm2226545d7-bc_24figure4c.jpg GRAPHIC 51214
56 GRAPHIC tm2226545d7-lc_25figure4c.jpg GRAPHIC 114520
57 GRAPHIC tm2226545d1-fc_figure254clr.jpg GRAPHIC 61049
58 GRAPHIC tm2226545d1-fc_summarbwlr.jpg GRAPHIC 223930
59 GRAPHIC lg_weiwei-4c.jpg GRAPHIC 49204
60 GRAPHIC lh_report-4c.jpg GRAPHIC 85923
61 GRAPHIC tm2226545d1-fc_organbw.jpg GRAPHIC 82731
62 GRAPHIC tm2226545d1-fc_yishe4c.jpg GRAPHIC 104393
63 GRAPHIC tm2226545d1-txt_chinese1bw.jpg GRAPHIC 17656
64 GRAPHIC tm2226545d1-txt_chinese2bw.jpg GRAPHIC 4679
65 GRAPHIC lg_valuescope-4clr.jpg GRAPHIC 30741
66 GRAPHIC ft_valuescope-4c.jpg GRAPHIC 37655
67 GRAPHIC tm2226545d23_ex23-2img001.jpg GRAPHIC 8152
68 GRAPHIC tm2226545d23_ex23-2img002.jpg GRAPHIC 10920
  Complete submission text file 0001104659-23-006384.txt   22678150
Mailing Address BUILDING NO. 2, 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK DAXING DISTRICT, BEIJING F4 102629
Business Address BUILDING NO. 2, 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK DAXING DISTRICT, BEIJING F4 102629 861089202086
YishengBio Co., Ltd (Filer) CIK: 0001946399 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: F-4/A | Act: 33 | File No.: 333-269031 | Film No.: 23549878
SIC: 2834 Pharmaceutical Preparations